blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1653994

EP1653994 - USE OF CXCL6 CHEMOKINE IN THE PREVENTION OR REPAIR OF CARTILAGE DEFECTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.10.2010
Database last updated on 11.09.2024
Most recent event   Tooltip28.09.2012Lapse of the patent in a contracting state
New state(s): LU		published on 31.10.2012  [2012/44]
Applicant(s)For all designated states
TIGENIX N.V.
Romeinse straat 12 bus 2
3001 Leuven / BE
[2010/11]
Former [2008/09]For all designated states
TIGENIX N.V.
Technologielaan 3
3001 Leuven / BE
Former [2006/19]For all designated states
Tigenix N.V.
Technologielaan 3
3001 Leuven / BE
Inventor(s)01 / LUYTEN, Frank
Baron D'Huartlaan 193
1950 Kraainem / BE
02 / DE BARI, Cosimo
18 Ethelbert Close
Bromley, Kent BR1 1JB / GB
03 / DELL'ACCIO, Francesco
150 Farnaby Road
Bromley, Kent BR2 0BB / GB
 [2006/19]
Representative(s)Bird, Ariane, et al
Bird Goën & Co
Wetenschapspark Arenberg
Gaston Geenslaan 9
3001 Heverlee / BE
[N/P]
Former [2006/19]Bird, Ariane, et al
Bird Goën & Co Klein Dalenstraat 42A
3020 Winksele / BE
Application number, filing date04761478.912.08.2004
[2006/19]
WO2004BE00117
Priority number, dateUS20030494516P12.08.2003         Original published format: US 494516 P
[2006/19]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005014026
Date:17.02.2005
Language:EN
[2005/07]
Type: A2 Application without search report 
No.:EP1653994
Date:10.05.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 17.02.2005 takes the place of the publication of the European patent application.
[2006/19]
Type: B1 Patent specification 
No.:EP1653994
Date:25.11.2009
Language:EN
[2009/48]
Search report(s)International search report - published on:EP17.03.2005
ClassificationIPC:A61K38/19, A61P19/00
[2006/19]
CPC:
A61K35/32 (EP,US); A61K38/19 (NO); A61K38/00 (NO);
A61K38/195 (EP,US); A61P19/00 (EP); A61P43/00 (EP)
C-Set:
A61K35/32, A61K2300/00 (US,EP);
A61K38/195, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/19]
Extension statesAL17.01.2006
HR17.01.2006
LT17.01.2006
LV17.01.2006
MK17.01.2006
TitleGerman:VERWENDUNG VON CXCL6 CHEMOKIN BEI DER PRÄVENTION ODER REPARATUR VON KNORPELDEFEKTEN[2006/19]
English:USE OF CXCL6 CHEMOKINE IN THE PREVENTION OR REPAIR OF CARTILAGE DEFECTS[2006/19]
French:UTILISATION D'UNE CHIMIOKINE CXCL6 DANS LA PREVENTION OU LA REPARATION DE DEFAUTS AU NIVEAU DU CARTILAGE[2006/19]
Entry into regional phase17.01.2006National basic fee paid 
17.01.2006Designation fee(s) paid 
17.01.2006Examination fee paid 
Examination procedure01.06.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.01.2006Amendment by applicant (claims and/or description)
17.01.2006Examination requested  [2006/19]
08.12.2008Despatch of a communication from the examining division (Time limit: M04)
17.04.2009Reply to a communication from the examining division
22.06.2009Communication of intention to grant the patent
14.10.2009Fee for grant paid
14.10.2009Fee for publishing/printing paid
Opposition(s)26.08.2010No opposition filed within time limit [2010/44]
Fees paidRenewal fee
17.01.2006Renewal fee patent year 03
21.08.2007Renewal fee patent year 04
12.08.2008Renewal fee patent year 05
04.08.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY25.11.2009
CZ25.11.2009
EE25.11.2009
RO25.11.2009
SI25.11.2009
SK25.11.2009
BG25.02.2010
PT25.03.2010
HU26.05.2010
LU12.08.2010
[2012/44]
Former [2012/42]CY25.11.2009
CZ25.11.2009
EE25.11.2009
RO25.11.2009
SI25.11.2009
SK25.11.2009
BG25.02.2010
PT25.03.2010
HU26.05.2010
Former [2010/39]CY25.11.2009
CZ25.11.2009
EE25.11.2009
RO25.11.2009
SI25.11.2009
SK25.11.2009
BG25.02.2010
PT25.03.2010
Former [2010/36]CY25.11.2009
CZ25.11.2009
EE25.11.2009
RO25.11.2009
SI25.11.2009
BG25.02.2010
PT25.03.2010
Former [2010/35]CY25.11.2009
EE25.11.2009
RO25.11.2009
SI25.11.2009
BG25.02.2010
PT25.03.2010
Former [2010/25]CY25.11.2009
SI25.11.2009
PT25.03.2010
Former [2010/23]SI25.11.2009
PT25.03.2010
Former [2010/22]PT25.03.2010
Cited inInternational search[DX]US5786217  (TUBO ROSS A [US], et al) [DX] 9-12 * claim - *;
 [DXA]US6410268  (NI JIAN [US], et al) [DX] 15 * column 25, line 29; example 4 * [A] 1-14,17-19;
 [DA]US6413511  (GLORIOSO JOSEPH C [US], et al);
 [DX]US2002123483  (SAXENA GEETA [CA], et al) [DX] 25,26 * paragraph [0016]; claim - *;
 [X]EP1312614  (GENODYSSEE [FR]) [X] 15 * claim 22 *;
 [DX]  - WUYTS ANJA ET AL, "The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: Comparison with interleukin-8/CXCL8.", LABORATORY INVESTIGATION, (200301), vol. 83, no. 1, ISSN 0023-6837, pages 23 - 34, XP002314496 [DX] 9-12,15-17,20-22,29-31 * page 25, column 2 - page 26, column 1; figure 4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.